In accordance with the Food and Drug Safety Administration's change order for pharmaceutical manufacturing (import) items (Drug Management Division-No. 5151, effective date 2009.5.20), the precautions for use of Inhipla Tablet, Silumin Capsule 11.3mg, and Silumin Capsule 16.95mg have been changed.
 


For further details, please refer to the ‘Product Introduction’ section and attached documents.